Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders
Imported from official source
MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.
This version
- Version
- 1 of 1
- Recorded
- October 30, 2026 16:00
- Change
- Initial
- Content hash
5832cf76b9389b857dadde3a1cd55a29- All versions
- Revision history